Delivery Order SPE2DE21D0029-SPE2D625F7PN5
- Not listed
- Becton, Dickinson and Company (BD), through its Infectious Diseases Systems (IDS) division, received a delivery order valued at $1,786.65 from the Department of Defense's Medical Supply Chain on July 31, 2025. The contract is a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, reflecting BD's competitive standing as a large medical technology manufacturer. Performance will be completed by August 21, 2025, at BD's facility in Sparks Glencoe,...
- Becton, Dickinson and Company (BD), through its Diagnostic Systems division, received a delivery order award from the Defense Department's Medical Supply Chain on August 15, 2025, valued at $3,573.30 with a fixed-price contract structure that includes economic price adjustment provisions. The delivery order, which concludes on September 8, 2025, represents a task order issued under a larger indefinite delivery/indefinite quantity contract or blanket purchase agreement. BD's Diagnostic Systems...
- Becton, Dickinson and Company's Infectious Disease Systems (IDS) division received a delivery order award valued at $2,079.30 from the Medical Supply Chain, a defense-oriented federal agency, with an ultimate completion date of November 10, 2025. The award, issued on November 3, 2025, represents a fixed-price contract with economic price adjustment provisions and carries no small business set-aside designation. The work will be performed at BD's facility in Sparks Glencoe, Maryland. This...
- Becton, Dickinson and Company (BD), through its Diagnostic Systems division, was awarded a delivery order valued at $3,402.60 by the Department of Defense's Medical Supply Chain on July 17, 2025, for the Kit Affirm VPIII Clinical. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 7, 2025, and will be performed in Sparks Glencoe, Maryland. The award was made on a full and open competition basis without set-aside designation, consistent...
- Becton, Dickinson and Company's Infectious Disease Systems division received a $1,122.00 delivery order award from the Defense Department's Medical Supply Chain on December 10, 2025, for tube culture media products (specifically 7ML BD BCTC BD MGIT BRCD MYCB items) with performance completion targeted for January 2, 2026. The contract utilizes a fixed-price structure with economic price adjustment provisions and will be performed in Sparks, Maryland. This delivery order represents a child...
- Becton, Dickinson and Company's Infectious Disease Systems division received a delivery order award on December 10, 2025, for the Kit Affirm VPIII Clinical under a fixed-price contract with economic price adjustment provisions. The award, valued at $1,361.04 with an ultimate completion date of January 2, 2026, supports the Defense Health Agency's Medical Supply Chain operations. The work will be performed in Sparks, Maryland. This delivery order was issued without a small business set-aside...
- Becton, Dickinson and Company's Infectious Diseases Systems (IDS) division was awarded a delivery order valued at $998,100.60 by the Defense Health Agency for BD MAX and consumables—a handheld medical device that performs nucleic acid extraction. This firm fixed-price delivery order, effective through September 18, 2028, is issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule contract. The award was made on a full and open competition basis...
- Becton, Dickinson and Company (BD) was awarded a firm fixed-price delivery order valued at $1,236.90 by the Defense Health Agency's Medical Supply Chain organization on June 2, 2025, with an ultimate completion date of June 5, 2025. The contract, which carries no small business set-aside designation, is for delivery to Franklin Lakes, New Jersey. As a globally recognized medical technology manufacturer, BD specializes in providing sophisticated medical devices, diagnostic products, and...
- Becton, Dickinson and Company, operating through its IDS division as BD Diagnostic Systems, has been awarded a firm fixed price delivery order against a Blanket Purchase Agreement by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2. The $5,630.22 order is for bacterial identification and susceptibility testing to be completed by March 31, 2026 at the specified place of performance in Sparks Glencoe, Maryland. As a leading manufacturer of...
- This federal contract award is for the delivery of specialized medical supplies and services to the U.S. government by Becton, Dickinson and Company (BD), a global medical technology manufacturer. The $1,786.65 fixed-price delivery order was awarded by the Medical Supply Chain, a defense agency, with an ultimate completion date of June 10, 2025. The contract does not have a set-aside designation, indicating BD competed effectively in the open federal marketplace. BD, through its IDS division,...
- SPE2DE21D0029Indefinite Delivery Contract
- SPE2DE21D0029-SPE2D625F7PN5Delivery Order
Becton, Dickinson and Company (BD), through its Infectious Disease Systems division, was awarded a delivery order valued at $1,560.00 by the Department of Defense's Medical Supply Chain on July 18, 2025, for enteric parasite diagnostic products and services. The contract employs fixed-price pricing with economic price adjustment and will be performed in Sparks Glencoe, Maryland, with an ultimate completion date of August 8, 2025. This delivery order was issued without a set-aside designation, reflecting BD's competitive position as an established medical technology provider. The award represents a task order issued under one of BD's existing Indefinite Delivery/Indefinite Quantity vehicles or Blanket Purchase Agreements with the Department of Defense or its subordinate agencies. BD's contract award aligns with the company's established role as a leading supplier of diagnostic testing equipment and reagents to federal healthcare agencies. The company's IDS division specializes in microbiology analyzers, molecular and infectious disease testing capabilities, and laboratory diagnostic solutions that support military and veteran healthcare delivery systems. This delivery order for enteric parasite diagnostics reflects the ongoing demand for specialized infectious disease diagnostic products within the Department of Defense's medical supply chain and demonstrates the continued reliance on BD's diagnostic portfolio to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/18/25 |